Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2007
08/14/2007US7255851 Non-invasive localization of a light-emitting conjugate in a mammal
08/09/2007WO2007089871A2 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
08/09/2007WO2007089866A2 Non-coiled protective regions of pneumococcal surface proteins pspa and pspc
08/09/2007WO2007089783A2 Tat-044 and methods of assessing and treating cancer
08/09/2007WO2007089690A2 Tat-042 and methods of assessing and treating cancer
08/09/2007WO2007089659A2 Tat-039 and methods of assessing and treating cancer
08/09/2007WO2007089612A2 Methods and compositions for treating and preventing bacterial infections
08/09/2007WO2007089470A2 Antigen-binding proteins targeting s. aureus orf0657n
08/09/2007WO2007089205A1 Colonization factor (cf) antigens of enterotoxigenic escherichia coli in recombinant bacteria
08/09/2007WO2007088712A1 Neuronal cell death inhibitor and screening method
08/09/2007WO2007088479A1 Methods for treating obesity by administering a trkb antagonist
08/09/2007WO2007087679A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor v
08/09/2007WO2007087673A1 Domain antibody construct
08/09/2007WO2007068907A3 Vaccine compositions comprising a saponin adjuvant
08/09/2007WO2007068902A3 Vaccine
08/09/2007WO2007068412A3 A beta 1-42 specific monoclonal antibodies with therapeutic properties
08/09/2007WO2007068354A8 Means and methods for the treatment of tumorous diseases
08/09/2007WO2007064742A3 Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus (prrsv) and uses thereof
08/09/2007WO2007054820A3 Manufacture of vaccines that contain both hepatitis b virus surface antigen and surfactant
08/09/2007WO2007054809A3 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
08/09/2007WO2007054283A3 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions
08/09/2007WO2007053781A3 Compositions with antigens adsorbed to calcium phosphate
08/09/2007WO2007053194A3 Modulation of cell barrier dysfunction
08/09/2007WO2007041637A3 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
08/09/2007WO2007027751A3 Immunomodulating tumor necrosis factor receptor 25 (tnfr25) agonists, antagonists and immunotoxins
08/09/2007WO2007021886A3 Truncated memapsin 2 for use for treating alzheimer's disease
08/09/2007WO2006138690A3 Improved method of treating degenerative spinal disorders
08/09/2007WO2006133396A3 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1) pathway
08/09/2007WO2006098887A3 Gene disruptions, compositions and methods relating thereto
08/09/2007WO2006050177A3 Antibodies that bind urokinase-type plasminogen activator and epitopes therefor
08/09/2007US20070186295 TAT-036 and methods of assessing and treating cancer
08/09/2007US20070186294 TAT-030 and methods of assessing and treating cancer
08/09/2007US20070185048 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders
08/09/2007US20070185026 Compositions and methods for treating bacteria
08/09/2007US20070185010 Novel Polypeptide Hormone Phosphatonin
08/09/2007US20070184465 Methods for regulating hematopoiesis using CpG-oligonucleotides
08/09/2007US20070184461 Novel Polypeptide Hormone Phosphatonin
08/09/2007US20070184074 Fusion proteins of Mycobacterium tuberculosis
08/09/2007US20070184073 TB diagnostic based on antigens from M. tuberculosis
08/09/2007US20070184072 Multivalent pneumococcal polysaccharide-protein conjugate composition
08/09/2007US20070184071 Multivalent pneumococcal polysaccharide-protein conjugate composition
08/09/2007US20070184070 Recombinant toxin fragments
08/09/2007US20070184069 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines
08/09/2007US20070184068 Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
08/09/2007US20070184065 Compositions and Methods for Inhibiting Viral Adhesion
08/09/2007US20070184064 Chimeric peptide immunogens
08/09/2007US20070184063 Production of Proteins Carrying Oligomannose or Human-Like Glycans in Yeast and Methods of Use Thereof
08/09/2007US20070184062 Promotes a prolonged, directed cytotoxic T cell response to the target cell; cancer; vaccine
08/09/2007US20070184058 Glucocerebroside treatment of pulmonary or respiratory diseases or disorders
08/09/2007US20070184057 Use of weak stressors to enhance the effectiveness of ionizing radiation and other treatments of disease
08/09/2007US20070184056 Use of weak stressors to enhance the effectiveness of ionizing radiation and other treatments of disease
08/09/2007US20070184055 Treatment with anti-erbb2 antibodies
08/09/2007US20070184054 polynucleotide encoding oocyst sporocyst protein (EtOs22); for finding active compounds for treating an infection with Eimeria
08/09/2007US20070184053 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
08/09/2007US20070184052 Soluble tgf-b type III receptor fusion proteins
08/09/2007US20070184051 Acute myeloid leukemia therapy
08/09/2007US20070184050 Stable water-based medicinal preparation containing antibody
08/09/2007US20070184049 Antibody therapy for treatment of diseases associated with gluten intolerance
08/09/2007US20070184048 Re-targeted toxin conjugates
08/09/2007US20070184047 Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction
08/09/2007US20070184037 T cell immune response inhibitor
08/09/2007US20070184031 Semi-mature dendritic cell coated with a bispecific antibody, binding to an antigenic surface molecule on a dendritic cell and to a T-cell receptor that suppresses T-cell activation
08/09/2007US20070184023 Method for down-regulation of vegf
08/09/2007US20070184022 Microsome vaccine
08/09/2007US20070183972 Compounds and methods for the treatment of cancer
08/09/2007US20070183971 Immunoconjugates targeting syndecan-1 expressing cells and use thereof
08/09/2007US20070183970 Chimeric, human and humanized anti-granulocyte antibodies and methods of use
08/09/2007US20070183969 Cln101 antibody compositions and methods of use alone and in combination with prostate specific antigen and other cancer markers
08/09/2007CA2676601A1 Vaccine delivery compositions and methods of use
08/09/2007CA2641220A1 Non-coiled protective regions of pneumococcal surface proteins pspa and pspc
08/09/2007CA2641026A1 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
08/09/2007CA2640661A1 Domain antibody construct
08/09/2007CA2640458A1 Lipoparticles comprising ion channels, methods of making, and using the same
08/09/2007CA2638834A1 Method for producing epitomers and their uses on carrier microorganisms
08/09/2007CA2638761A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor v
08/09/2007CA2637836A1 Ang2 and vegf inhibitor combinations
08/09/2007CA2637707A1 Methods for treating obesity by administering a trkb antagonist
08/09/2007CA2626804A1 Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
08/09/2007CA2622679A1 Immunostimulatory single-stranded ribonucleic acid with phosphodiester backbone
08/08/2007EP1816200A1 Postweaning multisystemic wasting syndrome virus for pigs
08/08/2007EP1816198A1 Variable fragments of immunoglobulins-use for therapeutic or veterinary purposes
08/08/2007EP1816140A1 Anti-glypican 3 antibody having modified sugar chain
08/08/2007EP1815864A1 Method of suppressing metastasis of cancer cells and medicinal composition to be used therefor
08/08/2007EP1815862A1 Isolated stromal cells for use in the tretment of diseases of the central nervous system
08/08/2007EP1815856A2 A cancer vaccine
08/08/2007EP1814917A2 Single domain camelide anti-amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenerative neural diseases such as alzheimer's disease
08/08/2007EP1814915A1 Neutralising antibody molecules having specificity for human il-17
08/08/2007EP1814914A2 Antibodies that bind urokinase-type plasminogen activator and epitopes therefor
08/08/2007EP1814903A2 Leucine-rich repeat (lrr) motif containing proteins
08/08/2007EP1814901A1 Citrulline peptides derived from fibrin and recognised by rheumatoid arthritis specific autoantibodies and the use thereof
08/08/2007EP1814595A1 Treatment of cancer with a combination of an agent that perturbs the egf signaling pathway and an oligonucleotide that reduces clusterin levels
08/08/2007EP1814586A2 Anti-properdin antibodies, and methods for making and using same
08/08/2007EP1814585A2 Methods and materials for the inhibition of transplant rejection
08/08/2007EP1814584A2 Ligands that enhance endogenous compounds
08/08/2007EP1814583A2 Combination approaches for generating immune responses
08/08/2007EP1814567A1 Use of modulators of epha2 and ephrina1 for the treatment and prevention of infections
08/08/2007EP1814516A1 Use of a liquid allergy vaccine formulation for oromucosal administration
08/08/2007EP1814514A2 Heavy chain and single domain antibodies
08/08/2007EP1814386A1 Methods of studying tolerance in mhc-ii transgenic animals
08/08/2007EP1480671B1 Recombinant rsv virus expression systems and vaccines
1 ... 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 ... 1823